Sign In
Buy HBIO
$6.50
+0.0400 (+0.619%)
At Close: Jun 03, 2026
Harvard Bioscience Announces CFO Transition
04:45pm, Thursday, 10'th Apr 2025
HOLLISTON, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of Jennifer Cote, the Company's Chief Financial Officer
Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025
04:00pm, Wednesday, 12'th Mar 2025
HOLLISTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Of
Harvard Bioscience, Inc. (HBIO) Q4 2024 Earnings Call Transcript
11:19am, Wednesday, 12'th Mar 2025
Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q4 2024 Results Conference Call March 12, 2025 8:00 AM ET Company Participants Kathryn Flynn - Corporate Controller Jim Green - Chairman, President & CEO Jennif
Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results
07:21am, Wednesday, 12'th Mar 2025
HOLLISTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the fourth quarter and full year ended December 3
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
04:45pm, Monday, 24'th Feb 2025
Advanced platforms for CROs, pharmaceutical and biotech companies seeking to enhance productivity Advanced platforms for CROs, pharmaceutical and biotech companies seeking to enhance productivity
Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET
11:00am, Monday, 24'th Feb 2025
HOLLISTON, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended December 31, 2024, before the market opens on Marc
Harvard Bioscience, Inc. to Participate in the Sidoti Micro Cap Conference
05:52pm, Monday, 13'th Jan 2025
HOLLISTON, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Off
Harvard Bioscience, Inc. (HBIO) Q3 2024 Earnings Call Transcript
09:37am, Saturday, 09'th Nov 2024
Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q3 2024 Results Conference Call November 7, 2024 8:00 AM ET Company Participants Kathryn Flynn - Corporate Controller James Green - Chairman, President and CEO
Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET
05:00pm, Tuesday, 29'th Oct 2024
HOLLISTON, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended September 30, 2024 before the market opens on Nove
2 Instruments Stocks to Watch From a Challenging Industry
03:51pm, Tuesday, 29'th Oct 2024
The Zacks Instruments - Scientific industry participants like MTD and HBIO are gaining from strong life science, pharmaceutical and academic end-market demand despite the challenging macroeconomic env
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting
07:30am, Wednesday, 18'th Sep 2024
Solutions for CROs, pharma and biotechs streamline testing and enable fundamental advancements in preclinical and organoid focused therapy development Solutions for CROs, pharma and biotechs streamlin
Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference
04:05pm, Thursday, 05'th Sep 2024
HOLLISTON, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Of
Harvard Bioscience, Inc. (HBIO) Q2 2024 Earnings Call Transcript
07:09am, Sunday, 11'th Aug 2024
Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q2 2024 Earnings Conference Call August 8, 2024 10:00 AM ET Company Participants Kathryn Flynn - Corporate Controller James Green - Chairman, President and CEO
Harvard Bioscience Announces Second Quarter 2024 Financial Results
08:30am, Thursday, 08'th Aug 2024
HOLLISTON, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the second quarter ended June 30, 2024.
Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET
08:00am, Friday, 02'nd Aug 2024
HOLLISTON, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2024 before the market opens on August 8,
